We are live on
!
Find out more
NRD
Nebula Research & Development Portfolio holdings
AUM
$1.17B
1-Year Est. Return
15.19%
This Fund
S&P 500
This Quarter
Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
(+35%)
Cap. Flow
+$188M
Cap. Flow
% of AUM
22.5%
Top 10 Holdings %
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$4.41M |
| 2 |
Advance Auto Parts
AAP
|
+$4.15M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$3.96M |
| 4 |
Dollar Tree
DLTR
|
+$3.82M |
| 5 |
Microsoft
MSFT
|
+$3.74M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$2.82M |
| 2 |
Coca-Cola
KO
|
+$2.82M |
| 3 |
General Dynamics
GD
|
+$2.82M |
| 4 |
Oracle
ORCL
|
+$2.81M |
| 5 |
Hamilton Lane
HLNE
|
+$2.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.51% |
| 2 | Industrials | 15.72% |
| 3 | Consumer Discretionary | 15.68% |
| 4 | Healthcare | 13.43% |
| 5 | Financials | 10.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
NET Power
NPWR
$133M
| $106K | 0.01% |
+15,162
| New | +$127K |
|
|
ARI
877
Apollo Commercial Real Estate
ARI
$877M
| $106K | 0.01% |
+11,480
| New | +$117K |
|
878
LXP Industrial Trust
LXP
$3.52B
| $101K | 0.01% |
+2,002
| New | +$99.9K |
|
|
NOVA
879
DELISTED
Sunnova Energy
NOVA
| $100K | 0.01% |
10,304
-11,661
| -53% | -$103K |
|
|
TERN
880
DELISTED
Terns Pharmaceuticals
TERN
| $94.5K | 0.01% |
+11,328
| New | +$93.2K |
|
881
Transocean
RIG
$5.67B
| $92.7K | 0.01% |
+21,807
| New | +$108K |
|
|
NPKI
882
NPK International
NPKI
$1.11B
| $88.3K | 0.01% |
12,746
-3,838
| -23% | -$29.5K |
|
|
MPT
883
Medical Properties Trust
MPT
$2.86B
| $88K | 0.01% |
15,037
-22,367
| -60% | -$110K |
|
884
American Vanguard Corp
AVD
$75.8M
| $87.8K | 0.01% |
+16,565
| New | +$117K |
|
885
SSR Mining
SSRM
$5.32B
| $86.9K | 0.01% |
+15,293
| New | +$80.1K |
|
886
Annexon
ANNX
$819M
| $85.9K | 0.01% |
+14,504
| New | +$86K |
|
887
Tango Therapeutics
TNGX
$4.25B
| $83.9K | 0.01% |
+10,901
| New | +$104K |
|
888
CryoPort
CYRX
$771M
| $83K | 0.01% |
+10,235
| New | +$83.7K |
|
889
Ecovyst
ECVT
$1.36B
| $81.1K | 0.01% |
+11,840
| New | +$90.2K |
|
|
RWT
890
Redwood Trust
RWT
$580M
| $78.3K | 0.01% |
10,130
-29,729
| -75% | -$217K |
|
891
Fortuna Silver Mines
FSM
$2.57B
| $72.6K | 0.01% |
+15,691
| New | +$74.4K |
|
|
EARN
892
Ellington Residential Mortgage REIT
EARN
$168M
| $72.5K | 0.01% |
+10,387
| New | +$72.2K |
|
|
SVM
893
Silvercorp Metals
SVM
$2.11B
| $72.3K | 0.01% |
16,547
-177,843
| -91% | -$660K |
|
894
Leslie's
LESL
$10.6M
| $70.8K | 0.01% |
+1,120
| New | +$69.1K |
|
895
Backblaze
BLZE
$678M
| $69.9K | 0.01% |
+10,932
| New | +$67.9K |
|
896
Ardagh Metal Packaging
AMBP
$2.99B
| $62.2K | 0.01% |
+16,502
| New | +$58.3K |
|
897
Energy Fuels
UUUU
$2.82B
| $57.5K | 0.01% |
+10,473
| New | +$54.5K |
|
898
Prospect Capital
PSEC
$1.13B
| $54.1K | 0.01% |
+10,118
| New | +$53.7K |
|
899
Taysha Gene Therapies
TSHA
$1.57B
| $43.7K | 0.01% |
+21,737
| New | +$47.7K |
|
900
Opendoor
OPEN
$3.73B
| $34.7K | ﹤0.01% |
+17,922
| New | +$36.4K |
|
Similar funds
SAF
GIM
CCM
PP
FC
HIP
SC
BWA
Nebula Research & Development's Q3 2024 Portfolio in Review
As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.
Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.
- Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
- Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
- Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
- Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
- Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
- Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
- Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.
Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.